Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,637 INR | +1.33% | +2.11% | +23.77% |
04-24 | Lupin Receives US FDA Inspection Report for Aurangabad, India Manufacturing Facility | MT |
04-22 | INDIA STOCKS-Indian shares rise tracking Asia rebound; drop in HDFC Bank caps gains | RE |
Sales 2024 * | 199B 2.38B 3.25B | Sales 2025 * | 217B 2.61B 3.56B | Capitalization | 746B 8.95B 12.21B |
---|---|---|---|---|---|
Net income 2024 * | 19.85B 238M 325M | Net income 2025 * | 23.23B 278M 380M | EV / Sales 2024 * | 3.88 x |
Net Debt 2024 * | 24.9B 298M 407M | Net Debt 2025 * | 9.52B 114M 156M | EV / Sales 2025 * | 3.48 x |
P/E ratio 2024 * |
37.4
x | P/E ratio 2025 * |
32
x | Employees | 20,933 |
Yield 2024 * |
0.44% | Yield 2025 * |
0.53% | Free-Float | 52.83% |
Latest transcript on Lupin Limited
1 day | +1.33% | ||
1 week | +2.11% | ||
Current month | +1.28% | ||
1 month | +0.84% | ||
3 months | +10.39% | ||
6 months | +43.59% | ||
Current year | +23.77% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 96-12-31 | |
Johnny Mikell
PSD | President | - | - |
Director of Finance/CFO | 59 | 07-08-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 15-10-26 | |
Mark McDade
BRD | Director/Board Member | 69 | 21-01-27 |
Director/Board Member | 50 | 95-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 1,637 | +1.33% | 1 294 998 |
24-04-26 | 1,616 | +1.35% | 587,789 |
24-04-25 | 1,594 | +0.91% | 1,203,147 |
24-04-24 | 1,580 | -0.00% | 1,363,206 |
24-04-23 | 1,580 | -1.47% | 849,166 |
Delayed Quote NSE India S.E., April 29, 2024 at 07:40 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.17% | 661B | |
+26.74% | 566B | |
-6.66% | 352B | |
+20.00% | 332B | |
+2.69% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-5.22% | 145B |
- Stock Market
- Equities
- LUPIN Stock
- LUPIN Stock